The Need to Screen Athletes for Pelvic Floor Dysfunction

Overall prevalence of pelvic floor dysfunction (PFD) ranges from 14.7%-45% within the athletic population (Culleon-Quinn 2022). Additional evidence supports the incidence of PFD within this population (Culleon-Quinn 2022, Rebullido et al 2021, Rodríguez-López et al 2020, Nygaard & Shaw 2016). The athletic population is disproportionately in need of pelvic health services – but much like the general population, many athletes are not aware of the signs and symptoms of PFD, so they may not know to seek care (Bosch-Donate et al, 2024, Cardoso et al, 2018).

In a recent publication in the International Journal of Sports Physical Therapy, a group of student and faculty researchers investigated a method of screening collegiate athletes for PFD as a component of the DPT students’ project to promote health in their communities. The intent of the study was to identify the incidence of PFD in collegiate athletes, assess for awareness of PFD, and explore psychosocial factors related to PFD in athletes.

Taking place at the DPT students’ university, student-athletes were recruited from multiple sports teams to participate in a generalized pelvic floor screening in two phases. In the first phase, students completed a demographics section as well as the Cozean Pelvic Dysfunction Screening Tool, a ten-item subjective screening tool. Athletes who scored a “3” or greater on the Cozean Pelvic Dysfunction Screening Tool were then invited to participate in the second phase of screening: a simple, external pelvic floor muscle (PFM) function assessment, performed by the researchers. The researchers chose this score due to the 91% specificity indicating possible PFD in individuals who score 3 or greater on the tool. (Cozean, N 2018)

The researchers performed an external PFM function assessment that included palpation of the coccyx over clothing. This external assessment allowed for improved comfort of the athletes as well as improved efficiency in the performance of the assessment. Coccygeal motion palpation was previously found to be valid when performed by clinicians without formal pelvic health training and was correlated with activation patterns shown via real-time ultrasound, demonstrating 94% sensitivity and 79% specificity in identifying PFM activation patterns (Maher & Iberle, 2020).

For the PFM function assessment, the researchers palpated the tip of the coccyx with the athlete in a seated position as described in the original 2020 study. Participants were then instructed to contract, release, and lengthen their pelvic floor muscles while the student researchers palpated the motion of the coccyx. As described in the validity study, student researchers identified whether or not the coccyx moved anteriorly, posteriorly, or not at all to infer the activity of the PFM. If the student researchers were unsure, the faculty research leader, a Board-Certified Women’s Health Clinical Specialist, and a Certified Pelvic Rehabilitation Practitioner were available on-site to confirm findings.

Once the coccygeal motion palpation was completed, the researchers assigned the athletes into one of three classifications of suspected PFM impairment:

• “normal PFM activity” indicating that the coccyx moved posteriorly with PFM lengthening and anteriorly with PFM contraction
• “increased tone/overactive PFM activity” indicating that the coccyx did not move posteriorly during lengthening, but did move anteriorly with contraction
• “decreased tone/underactive PFM activity” indicating that the coccyx moved posteriorly with lengthening, but did not move anteriorly with contraction

The researchers then shared information with the student athletes pertaining specifically to the suspected PFM impairment identified. Athletes were given information about the PFM, general exercises to consider, as well as resources for finding a trained PT if they desired more formal assessment and interventions.

A quarter (24.5%) of participants scored a “3” or greater on the subjective screening tool, with positive correlations with increased age, self-identified female gender, and increased knowledge of PFD. Swimming athletes were also found to have an increased incidence of positive screening scores as compared to other sports. Following coccygeal motion testing, 54% of the participants were identified as demonstrating “decreased tone/underactive PFM activity” and 39% were identified as demonstrating “increased tone/overactive PFM activity”.

Of the 13 athletes who scored positive on the Cozean Pelvic Dysfunction Screening Tool, 12 also demonstrated objective signs of increased or decreased tone of the PFM during coccygeal motion palpation, (92.3%) reinforcing the Cozean tool’s effectiveness as a simple subjective screening tool for PFD. Additionally, coccygeal motion palpation is a simple, non-invasive, objective screening method that can be taught to clinicians who do not have formal training in pelvic health, allowing for screening to be performed efficiently by all clinicians, and addressing a critical barrier to receiving care.

The results of this study highlight that PFD is often present in physically fit individuals who are competitive athletes. Additionally, 69% of the athlete participants presenting with suspected PFD reported feelings of embarrassment, anxiety, worry, or annoyance with regard to their symptoms, and 62% reported feelings of frustration. 69% of the athletes presenting with suspected PFD reported feeling as though PFD had an effect on athletic performance and 77% reported that PFD had an impact on their personal life. These qualitative findings illustrate that beyond the physical impact of PFD, there is a psychosocial impact as well. By implementing a PFD screening process for athletes, clinicians without formal pelvic health training can help identify athletes who may be experiencing PFD and serve as the initial point of contact to help athletes function better, both on and off the playing field.

By performing screening with a subjective screening tool and an external pelvic floor muscle assessment, the researchers were able to identify athletes demonstrating subjective and objective characteristics of PFD efficiently, while also emphasizing participant comfort. Taking this innovative approach to PFM assessment, it is much more feasible to integrate pelvic floor screening into a standard sports screening performed by a general physical therapist or athletic trainer. Once identified, those professionals can facilitate referral to a physical therapist with pelvic health training for more thorough assessment and treatment. This would allow more athletes with PFD to receive access to care and could have implications for both athletic performance as well as quality of life.

Interested in learning more? Come and see this group speak at APTA’s Combined Sections Meeting in 2025 where they’ll present an educational session about the study and discuss the implementation of this screening process to help ensure that athletes with PFD are identified sooner and receive access to care efficiently.

You can read the published research article, "Screening for Incidence and Effect of Pelvic Floor Dysfunction in College-Aged Athletes," here: https://ijspt.org/screening-for-incidence-and-effect-of-pelvic-floor-dysfunction-in-college-aged-athletes/.

AUTHOR BIO
Ashlie Crewe Campitella, PT, DPT, WCS, PRPC

Dr. Ashlie Crewe Campitella earned her Bachelor of Psychology and Doctorate of Physical Therapy at Gannon University prior to beginning her pelvic health training. She is a board-certified women’s health clinical specialist (WCS) and has her certification as a pelvic health practitioner (PRPC) through the Herman and Wallace Pelvic Rehabilitation Institute. 

Ashlie has developed pelvic health continuing education that is comprehensive and inclusive of all genders through the Institute of Advanced Musculoskeletal Treatments, where she is now a lead instructor. She also serves as the Pelvic Health Development Program Coordinator for Upstream Rehabilitation Institute. Additionally, Ashlie is a member of the International Pelvic Pain Society, and the Global Pelvic Health Alliance and serves as an adjunct faculty member at Lebanon Valley College, as well as on the medical advisory board for the Lichen Sclerosus Support Network. She remains in clinical practice in Harrisburg, Pennsylvania, treating patients of all ages and genders with pelvic health complaints, with a special focus on implementing a pain neuroscience and trauma-informed approach to pelvic health treatment.